CLINICAL TRIALS & RESEARCH
Resources

Response To FDA’s Request For Comments On Strategic Priorities For The Office Of Minority Health And Health Equity (OMHHE)

Public Comments

Comments provided on: June 29, 2020

Comments provided to: Food and Drug Administration (FDA)